On 1st September 2014, IPO published their revised guidelines for the examination of patent applications in the field of pharmaceuticals. The guidelines serve as supplementary to the practices and procedures followed by the Patent Office as published in other Patent office publications. Some of the important provisions covered under these guidelines include Section 2, Section 3, Claims of pharmaceutical inventions, etc.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
